Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.

Effects of newer antipsychotics on extrapyramidal function.

Tarsy D, Baldessarini RJ, Tarazi FI.

CNS Drugs. 2002;16(1):23-45. Review. Erratum in: CNS Drugs. 2003;17(3):202.

PMID:
11772117
2.

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.

Friedman JH, Factor SA.

Mov Disord. 2000 Mar;15(2):201-11. Review.

PMID:
10752567
3.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
4.

EPS profiles: the atypical antipsychotics are not all the same.

Weiden PJ.

J Psychiatr Pract. 2007 Jan;13(1):13-24. Review.

PMID:
17242588
5.

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

Barnes TR, McPhillips MA.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S49-57. Review.

PMID:
9690971
6.

Atypical antipsychotics in the EPS-vulnerable patient.

Friedman JH.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:39-51. Review.

PMID:
12504071
7.

Tolerability profile of atypical antipsychotics in children and adolescents.

Stigler KA, Potenza MN, McDougle CJ.

Paediatr Drugs. 2001;3(12):927-42. Review.

PMID:
11772153
8.
9.

Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder.

Gentile S.

J Clin Psychopharmacol. 2007 Feb;27(1):35-45. Review.

PMID:
17224710
10.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

11.
12.

Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria.

Gerlach J.

Ann Clin Psychiatry. 2002 Mar;14(1):47-57. Review.

PMID:
12046640
13.
14.

The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.

Miller CH, Mohr F, Umbricht D, Woerner M, Fleischhacker WW, Lieberman JA.

J Clin Psychiatry. 1998 Feb;59(2):69-75.

PMID:
9501888
15.

[Atypical antipsychotics in the elderly].

van Melick EJ; Werkgroep Klinische Gerontofarmacologie..

Tijdschr Gerontol Geriatr. 2004 Dec;35(6):240-5. Review. Dutch.

PMID:
15704604
16.

Behavioural pharmacology of the new generation of antipsychotic agents.

Moore NA.

Br J Psychiatry Suppl. 1999;(38):5-11. Review.

PMID:
10884895
17.
18.

Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.

Andrew HG.

Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S76-80. Review.

PMID:
7874668
19.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
20.

Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.

Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.

J Clin Psychiatry. 1997 Jul;58(7):318-22.

PMID:
9269253
Items per page

Supplemental Content

Support Center